Transfusion Medicine

Papers
(The median citation count of Transfusion Medicine is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information16
Author Index16
The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major16
13
Iron deficiency in whole blood donors in a resource‐poor setting: A cross‐sectional study in Uganda12
Role of disruptions in O RhD negative donations in Colombia on increasing maternal mortality ratio from haemorrhage11
Drivers of blood use in paediatric trauma: A retrospective cohort study10
Recruiting racialised youth to a stem cell registry in Canada10
2021: That was the year that was10
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach9
Severe acute haemolytic transfusion reaction secondary to a plasma incompatible group B platelet transfusion9
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis9
Reflection from managing blood supply during social unrest9
Hemolysis during therapeutic plasma exchange: A rare phenomena8
Cold agglutinin syndrome in a patient with anaemia and beta‐thalassemia trait8
Plenary session III8
Issue Information7
SHOT UK Collaborative Reviewing and Reforming IT Processes in Transfusion (SCRIPT) survey: Laboratory information management systems: Are we ready for digital transformation?7
Real world reduction in red cell transfusion with restrictive transfusion threshold in haematology inpatients6
CEBPA and GATA2 mutation and a transient blood group discrepancy in a patient with acute myeloid leukaemia6
A possible dose‐response equation: Viral load after plasma infusion in COVID‐19 patients and anti‐SARS‐CoV‐2 antibody titers in convalescent plasma6
Issue Information6
Placebo and nocebo effects in transfusion medicine6
Rhnull phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene6
6
A safety comparison of heparin and argatroban anticoagulation in veno‐venous extracorporeal membrane oxygenation with a focus on bleeding6
Lipidomic changes occurring in platelets during extended cold storage6
Pitfalls of reasoning in hospital‐based transfusion medicine5
Serological and molecular characterisation of the most prevalent weak D variants in Croatian population5
Paroxysmal cold hemoglobinuria: A diagnostic dilemma in a paediatric patient5
Preventative plasmapheresis in a diabetic pregnant patient with hypertriglyceridemia and distal pancreatectomy5
Author index5
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia5
Issue Information5
Plenary II5
Improved detection of hepatitis C virus‐positive blood donors and determination of infection status5
Poster Presentations4
Deviations in red cell blood component temperature during laboratory processing and at blood return monitored by a time–temperature indicator device4
Abstracts for the Australian and New Zealand Society of Blood Transfusion (ANZSBT) stream of the BLOOD 2022 Meeting 11th – 14th September 2022, Sydney, Australia4
4
Identification of two novel RHD and one novel RHCE gene promoter variants in Chinese Han blood donors4
D−− phenotype in a South Indian family: A multicentric approach to workup and management4
Evaluation of Dengue, Zika virus, and Chikungunya virus transmission by blood components in recipients of haematopoietic stem cell transplantation4
Motivations for blood donation by HIV‐positive individuals on antiretrovirals in South Africa: A qualitative study4
4
3
The use of predictive modelling to determine the likelihood of donor return during the COVID‐19 pandemic3
The contribution and potential of older blood donors in Asia Pacific regions3
Effects of cryopreservation on gram‐positive bacteria contaminants in umbilical cord blood3
Lessons learned from the CONCOR‐1 trial3
An accurate genetic assay to identify human neutrophil antigen 2 deficiency3
High B‐cell activating factor levels in multi‐transfused thalassemia patients3
Primary or anamnestic antibody response to the D antigen (RhD)after bone grafting: Case report and implications3
Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia3
Chikungunya and Mayaro infective viruses in components of blood3
Acute pancreatitis from a delayed haemolytic transfusion reaction3
Prevalence of anaemia among blood donors in eastern Morocco: The need for pre‐donation haemoglobin assessment3
A review of immunoglobulin use in a district general hospital setting3
Exploring the increasing need for plasma collection: Perspectives of voluntary nonremunerated donors on payment for plasma in Canada3
3
Issue Information3
Hyperhaemolysis caused by anti‐HI antibodies in a patient with myelodysplastic syndrome following a first ever red cell transfusion3
Evidence cornered: Transfusion evidence summary—efficacy and safety of early administration of 4‐factor prothrombin complex concentrate in patients with trauma at risk of massive transfusio3
Impact of elevated leukocyte levels on ABO blood group typing and cross‐matching3
Issue Information3
Red blood cell transfusion in myelodysplastic syndromes: A systematic review3
Universal new blood cell elution method with extensive phenotyping2
Understanding hepcidin for iron management in pregnancy2
Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England2
2
Reflections of a re‐engaged donor. A response to ‘on consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities’2
Ferritin‐guided management of blood donors with a marginally low pre‐donation haemoglobin and its effect on the number of donations in the following 3 years2
Plenary session I2
Safe handovers: Safe patients‐why good quality structured handovers in the transfusion laboratory are important2
Apheresis procedures for the treatment of patients and for the collection of cellular therapy products: A British Society for Haematology guideline2
Severe fetal anaemia due to red cell alloimmunisation in a Rhnull woman: A case report2
Apparent changes in RhD status during pregnancy: A case study of weak D variant due to RHD*DAU‐22
Issue Information2
Evidence Cornered: Transfusion Evidence Summary – Platelet transfusion before CVC placement in patients with thrombocytopenia (PACER trial)2
Bone marrow changes in a fatal case of transfusion associated—Graft versus host disease2
A rapid review of strategies to manage low iron levels in adults donating whole‐blood: A focus on donor behaviour2
What is best practice for the prevention of anti‐D alloimmunisation in D‐negative recipients receiving solid organ transplants from D‐positive donors2
Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006–20152
Factors affecting the efficacy of human leukocyte antigen‐selected platelet provision: A large retrospective study in the United Kingdom2
2
Knowledge and attitudes of apheresis donors regarding apheresis blood donation2
Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection2
Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1b: Case report and literature review2
Blood loss and transfusion risk in intramedullary nailing for subtrochanteric fractures2
Fresh frozen plasma: Beyond coagulation factor content2
BGvar: A comprehensive resource for blood group immunogenetics2
2
Review of transfusion practice for beta thalassaemia major patients in Scotland after removal of age criteria for red cell transfusion2
Plenary session III2
Issue Information2
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation2
Identification of a novel RHCE*Ce (829G > A) allele associated with absence of C and e antigens expression2
SARS‐CoV‐2 infection in the blood transfusion setting2
Intravenous immunoglobulin alteration in response to adverse reactions in neurological conditions: A retrospective cohort study2
Prevalence and incidence of transfusion‐transmissible infections among blood donors in Malawi: A population‐level study1
A challenge for blood management: A patient presenting anti‐Vel antibody undergoing orthotopic liver transplantation1
The importance of need‐altruism and kin‐altruism to blood donor behaviour for black and white people1
Blood transfusion needs in COVID‐19 patients: An observational prospective unicentric study1
Corrigendum1
The use of prothrombin complex concentrate in chronic liver disease: A review of the literature1
Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia1
Issue Information1
Plenary III1
Issue Information1
Critical appraisal of knowledge, attitude and practice studies for blood donation in India1
Issue Information1
SARS‐CoV‐2‐associated warm autoimmune haemolytic anaemia in an immunosuppressed patient: The trend continues1
Prevalence, incidence, risk factors and residual risk associated with viral infections among eligible Brazilian blood donors1
Does decreasing the incubation period used in the antibody screen affect its sensitivity?1
Suggested blood donor deferral strategy regarding hepatitis B infections in China1
Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt‐Jakob disease: The SaBTO review1
1
1
E‐learning/online education in transfusion medicine: A cross‐sectional international survey1
A case report of a rare p phenotype individual and a review of molecular biological analysis of p phenotype in the Chinese population1
Prevalence and specificity of red blood cell antibodies in patients transfused in tertiary hospitals in Burkina Faso1
Anti‐AnWj antibody induced haemolytic transfusion reaction in a patient with primary acquired pure red cell aplasia1
The efficacy and safety of therapeutic thrombocytapheresis in patients with extreme thrombocytosis1
Evaluation of platelet concentrates prepared using different methods after overnight holding (18–24 h) of whole blood at room temperature1
Abstracts for the Australian and New Zealand Society of Blood Transfusion (ANZSBT) Stream of the BLOOD 2023 Meeting 5th – 8th November 2023, Melbourne, Australia1
Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP1
Oral Abstracts1
UK national survey of anticoagulation in extra‐corporeal photopheresis—Is it time for a UK consensus statement?1
Notes from the Basho of the blood service1
Cost analysis of care and blood transfusions in patients with Major Obstetric Haemorrhage in Ireland1
Validation of current commercially‐available devices to thaw pooled, solvent/detergent‐treated human plasma1
Wednesday 18 September 2024 Simultaneous sessions1
Assessing motivations for non‐living and living organ donation among individuals with and without a history of blood donation1
Validation of the Sysmex XN analyser and Blood Bank mode for the quality and safety of donor blood and transfusion products1
Plenary I1
A second look at the mortality in thrombotic thrombocytopenic purpura score: An external validation study1
Issue Information1
Amber coloured plasma—Case for illustration1
Pure red cell aplasia after ABO incompatible allogeneic stem cell transplantation treated with therapeutic plasma exchange: A case report1
Plasma exchange in acute hemolytic reaction due to ABO‐incompatible erythrocyte concentrate transfusions: Single center experience1
Guideline for the investigation and management of red cell antibodies in pregnancy: A British Society for Haematology guideline1
Evaluation of two temperature storage conditions for full blood count samples from Lifeblood's donors1
Thursday 15th September 2022 Simultaneous sessions1
Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo1
1
Issue Information1
Issue Information1
Extended red blood cell matching for all transfusion recipients is feasible1
On consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities1
Double or nothing: Costs of duplicate haematinic ordering in medical inpatients1
Transfusing selected RhD negative patients with RhD positive packed red cell concentrates resulted in lower frequency of anti‐D development and saved almost two thousand RhD1
Splanchnic‐cerebral oxygenation ratio associated with packed red blood cell transfusion in preterm infants1
Poster session1
Preventing misinterpretation of rare blood types in clinical laboratories: A case study on B3 phenotype1
Quantitation of residual D positive red cells in D negative recipients of D positive solid organ transplants1
Recurrent pregnancy loss in a patient with anti‐Rh171
Acute haemolytic transfusion reaction after transfusion of fresh frozen plasma in a neonate—Preventable by using solvent/detergent‐treated pooled plasma?1
Issue Information0
Every minute counts: A comparison of thawing times and haemostatic quality of plasma thawed at 37°C and 45°C using four different methods0
Wednesday 11 October 2023 Simultaneous Sessions0
Hemolytic disease of the fetus and newborn in a Chinese blood group Di(a + b+) neonate caused by maternal anti‐Dib antibodies0
Alloimmunisation rate of patients on Daratumumab: A retrospective cohort study of patients in England0
Oral presentations0
Determining the strength of evidence for an association between sexual indicators and risk of acquiring HIV and sexually transmitted infections: Providing evidence for blood donation policy change0
Evaluating the appropriateness of fresh frozen plasma transfusions in two tertiary teaching hospitals0
Molecular validation of pathogen‐reduction technologies using rolling‐circle amplification coupled with real‐time PCR for torquetenovirus DNA quantification0
Corrigendum0
Comparison of European recommendations about patient blood management in postpartum haemorrhage0
HLA class I and HPA9b related fetal‐neonatal alloimmune thrombocytopenia0
Author Index0
Wednesday 18 September 2024 Simultaneous Sessions0
Issue Information0
A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe respiratory viral infections due to coronaviruses or influenza0
Successful haematopoietic progenitor cell collection by plerixafor in combination with reduced dose granulocyte colony‐stimulating factor for severe hypoxemia provoked by high‐dose granulocyte colony‐0
A rapid review of motives and barriers for living substance of human origin donation and an extended typology0
Probable cefepime‐induced immune mediated hemolytic anaemia0
Alloanti‐Hy in antenatal patients: A multi‐case review0
Challenges in recognising paroxysmal cold hemoglobinuria0
Issue Information0
Issue Information0
Serological investigations on penicillin‐induced antibodies in the Thai population0
Beyond COVID‐19 and lessons learned in the United States0
Emergency red cell exchange for the management of acute complications in sickle cell disease: Automated versus manual0
Changing red blood cell transfusion practice in obstetrics and gynaecology: A before and after study of hospital‐wide education0
Characterising practice patterns of human derived, lyophilized coagulation concentrates within the trauma quality improvement program registry0
Issue Information0
Analysis of a 5‐year, evidenced‐based, rational blood utilisation project in a South African regional hospital0
Cultured CD71+ erythroid cells modulate the host immune response0
The experience of the Turkish Red Crescent blood banks in the 2023 Türkiye earthquake0
Risk of transfusion‐associated malaria in sub‐Saharan Africa: The case of Mali0
Wednesday 14 September 2022 Simultaneous Session0
Demographic, clinical, and biochemical predictors of pica in high‐intensity blood donors0
Syphilis in a blood bank in Argentina: Prevalence trends and risk factors0
Construction of a decision model for donor testing in cases of suspected antibody‐mediated transfusion‐related‐acute‐lung‐injury0
Red blood cell inventory management: Insights from transfusion laboratory technologists in British Columbia, Canada0
Introduction of EUBIS standards to upgrade inspections of blood establishments to improve the safety of blood transfusion: The Polish experience0
Using trends and outliers in managing delayed transfusions0
Early alloimmunization in an infant to red cell antigens—Rare but possible in the ‘right’ circumstances0
The infected blood inquiry: Impact on public perceptions of blood supply risk, safety, and donation attitudes0
Frequency of red blood cell phenotypes from genotyped Australian blood donors0
0
Issue Information0
‘Old is gold’ does conventional test tube method still reign supreme? An immuno‐haematological survey of anti‐D detection and titration in ante‐natal cases among major hospitals across India0
Thursday 19 September 2024 Simultaneous Sessions0
Tuesday 10 October 2023 Sig Session0
Utility of rotational thromboelastometry in the management of massive haemorrhage at a regional Australian hospital0
Blood donation practices, motivators and barriers in the Caribbean: A narrative review0
Variability in viscoelastic haemostatic assay in major haemorrhage protocols: A unified approach or mixed signals?0
Anti‐Ce in haemolytic disease of the foetus and newborn0
Convalescent plasma and COVID‐19: Time for a second—second look?0
A critical contribution in a time of crisis: Examining motivations and deterrents to COVID‐19 convalescent plasma donation and future donation intentions among prospective Canadian0
Risk factors for red blood cell alloimmunization in patients with hematologic malignancy0
Poster Presentations0
Reactions to serum eye drops—New Zealand experience and review of the literature0
Blood transfusion in injured older adults: A retrospective cohort study0
Issue Information0
Monitoring iron stores in Icelandic blood donors from 1997 through 20190
0
Plenary session II0
Leukocytapheresis in the management of adults with acute myeloid leukaemia: A survey of AML treating centres highlighting variability in practice0
Mapping the blood transfusion supply in the west region of Cameroon: A cross‐sectional study0
Resuscitation of adult shocked trauma patients using major haemorrhage protocol guided by viscoelastic haemostatic assays versus formulaic approach0
A prospective interventional study to assess the impact of a ‘structured compact training’ on knowledge and skills of safe blood transfusion practices among nurses working in a tertiary care institute0
Issue Information0
Poster session0
Optimising platelet usage during the induction therapy of acute myeloid leukaemia: Impact of physician education0
0
Factors influencing white blood cell mobilisation in healthy granulocyte donors0
Corrigendum0
Using a scenario approach to assess for the current and future demand of immunoglobulins: An interview and literature study from The Netherlands0
Prevention strategies for vasovagal reaction in whole blood donors: A quadri‐armed randomised control trial0
Issue Information0
Author index0
Issue Information0
ABO(H) and Lewis blood group substances and disease treatment0
Establishment and discussion of autoverification rules for transfusion compatibility testing0
Author Index0
0
Serologic investigation and management of an antibody screen negative para‐Bombay phenotype during pregnancy0
Accuracy of RHC/c genotyping in Chinese Han population0
0
Rh(D) immune globulin administration in pregnancy: Retrospective audit of patient safety events followed by targeted educational intervention with Bayesian analysis0
Analysis of the effect and influencing factors of a clinical competency‐oriented prospective pre‐job training programme on the comprehensive ability of new employees in the department of transfusion m0
Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa0
Effects of storage on quality and function of acid‐treated platelets with reduced HLA Class I surface expression0
Blood donor notification of variant Creutzfeldt–Jakob disease risk: Lessons in communicating donor deferral and risk0
Speaker sessions0
Acute normovolemic haemodilution to reduce allogeneic red blood cell transfusion in patients undergoing coronary artery bypass grafting. An observational study0
Improvement of the understanding of blood donors with human T‐cell leukaemia virus type 1 using a new information booklet0
0
0.076752901077271